awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28069975-67024A92-B9EC-4550-A5F6-843C04575717
Q28069975-67024A92-B9EC-4550-A5F6-843C04575717
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069975-67024A92-B9EC-4550-A5F6-843C04575717
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
P2860
Q28069975-67024A92-B9EC-4550-A5F6-843C04575717
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069975-67024A92-B9EC-4550-A5F6-843C04575717
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10976db9da88420e836d38015fce2ca217eb4af0
P2860
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis.